About Us
Markets
Research
Services
NRI Corner
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
+13 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Technicals
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Divident
Right Issues
Split Of Facevalue
Summary
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Profit & Loss
Jubilant Pharmova Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code:
530019
NSE Symbol:
JUBLPHARMA
P/E :
297.46
ISIN Demat:
INE700A01033
Div & Yield %:
0.54
EPS :
3.09
Book Value:
144.30
Market Cap (Rs. Cr.):
14,642.06
Face Value :
1
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
INCOME :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Sales Turnover
784.70
810.10
87.75
2,709.50
3,139.90
3,438.61
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
784.70
810.10
87.75
2,709.50
3,139.90
3,438.61
Other Income
103.40
137.90
125.87
47.88
173.23
78.00
Stock Adjustments
-39.00
-3.50
0.00
-55.21
108.32
-46.74
Total Income
849.10
944.50
213.62
2,702.17
3,421.45
3,469.87
EXPENDITURE :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Raw Materials
316.50
411.10
0.00
1,395.15
1,792.74
2,006.07
Power & Fuel Cost
68.40
75.40
9.27
280.40
369.20
358.28
Employee Cost
190.00
167.30
49.21
220.67
264.90
265.71
Other Manufacturing Expenses
59.60
49.00
0.91
216.91
269.07
255.24
Selling & Administrative Expenses
88.60
93.00
26.84
100.02
143.14
138.82
Miscellaneous Expenses
6.10
7.70
8.29
14.07
39.96
46.87
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
729.20
803.50
94.54
2,227.23
2,879.02
3,070.99
Operating Profit
119.90
141.00
119.09
474.94
542.44
398.87
Interest
29.90
18.50
30.59
101.80
136.20
128.96
Gross Profit
90.00
122.50
88.50
373.14
406.24
269.91
Depreciation
48.30
43.20
6.25
99.97
107.40
86.48
Profit Before Tax
41.70
79.30
82.25
273.17
298.84
183.43
Tax
6.80
13.80
13.66
45.44
26.13
31.08
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
3.30
15.60
-9.91
13.25
-48.43
4.72
Reported Net Profit
31.60
49.90
78.50
214.48
321.14
147.63
Extraordinary Items
-0.76
0.25
0.01
-0.19
-4.92
-4.47
Adjusted Net Profit
32.36
49.65
78.49
214.67
326.06
152.10
Adjustment below Net Profit
0.00
-0.70
0.25
-212.82
-3.49
-9.46
P & L Balance brought forward
1,123.60
1,154.00
1,154.92
1,153.26
986.93
951.70
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
79.60
79.60
79.64
0.00
151.32
102.95
P & L Balance carried down
1,075.60
1,123.60
1,154.03
1,154.92
1,153.26
986.93
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
500.00
500.00
500.00
500.00
500.00
450.00
Dividend Per Share(Rs)
5.00
5.00
5.00
5.00
5.00
4.50
Earnings Per Share-Unit Curr
1.99
3.14
4.93
13.46
20.16
9.27
Earnings Per Share(Adj)-Unit Curr
1.99
3.14
4.93
13.46
17.49
8.04
Book Value-Unit Curr
149.34
151.86
80.47
80.51
163.67
146.91
Book Value(Adj)-Unit Curr
149.34
151.86
80.47
80.51
142.03
127.49